0000704415-16-000070.txt : 20160415 0000704415-16-000070.hdr.sgml : 20160415 20160415163514 ACCESSION NUMBER: 0000704415-16-000070 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20160415 DATE AS OF CHANGE: 20160415 EFFECTIVENESS DATE: 20160415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHWAYS, INC CENTRAL INDEX KEY: 0000704415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 621117144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19364 FILM NUMBER: 161574851 BUSINESS ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 6156144929 MAIL ADDRESS: STREET 1: 701 COOL SPRINGS BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHWAYS INC DATE OF NAME CHANGE: 20000322 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HEALTHCORP INC /DE DATE OF NAME CHANGE: 19940211 DEFA14A 1 defa14a.htm FORM DEFA 14A



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.    )
Filed by the Registrant                              Filed by a Party other than the Registrant  
Check the appropriate box:
 
         
 
Preliminary Proxy Statement
   
 
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
 
Definitive Proxy Statement
   
 
Definitive Additional Materials
   
 
Soliciting Material Pursuant to §240.14a-12
 
HEALTHWAYS, INC.
(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
   
 
No fee required.
   
 
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
     
 
 
(1)
 
Title of each class of securities to which transaction applies:
 
 
 
(2)
 
Aggregate number of securities to which transaction applies:
 
 
 
(3)
 
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
 
 
(4)
 
Proposed maximum aggregate value of transaction:
 
 
 
(5)
 
Total fee paid:
 
   
 
Fee paid previously with preliminary materials.
   
 
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     
 
 
(1)
 
Amount Previously Paid:
 
 
 
(2)
 
Form, Schedule or Registration Statement No.:
 
 
 
(3)
 
Filing Party:
 
 
 
(4)
 
Date Filed:
 

 

*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on May 26, 2016
 
HEALTHWAYS, INC.
 
 
 
Meeting Information
Meeting Type: Annual Meeting
For holders as of: March 31, 2016
Date: May 26, 2016     Time: 8:30 AM CDT
Location: Healthways, Inc.
Corporate Headquarters
701 Cool Springs Boulevard
Franklin, Tennessee 37067
 
 
Healthways, Inc.
C/O Computershare Investor Services
P.O. Box 43078
Providence, RI 02940
 
You are receiving this communication because you hold shares in the above named company.

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
 
 
See the reverse side of this notice to obtain proxy materials and voting instructions.


— Before You Vote —
How to Access the Proxy Materials
 
Proxy Materials Available to VIEW or RECEIVE:
 
1. Annual Report 2. Notice & Proxy Statement
 
How to View Online:
Have the information that is printed in the box marked by the arrow   (located on the following page) and visit: www.proxyvote.com.
 
How to Request and Receive a PAPER or E-MAIL Copy:
 
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET:     www.proxyvote.com
2) BY TELEPHONE1-800-579-1639
3) BY E-MAIL*:          sendmaterial@proxyvote.com
 
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow    (located on the following page) in the subject line.
 
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 12, 2016 to facilitate timely delivery.
 
 
 
— How to Vote —
Please Choose One of the Following Voting Methods
 
 
Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow   available and follow the instructions.
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
 
 

 
Voting Items
 
 
The Board of Directors recommends you vote FOR each of the following:
 
 
1.  Election of Directors
 
 
 
Nominees
 
 
3. To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year ending December 31, 2016.
1a. Mary Jane England, M.D.
 
 
1b. Archelle Georgiou, M.D.
 
 
1c. Robert J. Greczyn, Jr.
 
 
 
1d. Peter A. Hudson, M.D.
 
 
NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.
 
1e. Bradley S. Karro
 
 
1f. Paul H. Keckley, Ph.D.
 
 
 
1g. Conan J. Laughlin
 
 
 
1h. Lee A. Shapiro
 
 
 
1i. Donato J. Tramuto
 
 
 
1j. Kevin G. Wills
 
 
 
The Board of Directors recommends you vote FOR proposals 2 and 3.
 
 
2. To consider and act upon a non-binding advisory vote to approve executive compensation as disclosed in the Proxy Statement.
 
 

 
 
 

 
 
 
GRAPHIC 2 image1.jpg begin 644 image1.jpg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image2.jpg begin 644 image2.jpg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end GRAPHIC 4 image3.jpg begin 644 image3.jpg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end GRAPHIC 5 image4.jpg begin 644 image4.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1#Z17AI9@ 34T *@ @ ! $[ ( M 0 (2H=I 0 ! (6IR= $ @ 0TNH< < @, /@ M FMC.60G/SX- M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1& M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#Z1HHKQ^2\ MO-2\9W7AO6O%UK%8Q7=S-&EAJ,\5W*['=%"7V*HV#/R*Y/ R,5+E;\_N#I<] M@HK \"WMUJ7@#0[W4)S<7,]E$\LI'+DJ.3[^M;]:2CRR<>PD[JX5C+X6TE-( MO=-DM%NK2[GDN7@GPR[W;7>)M-^$EOXDG3Q'>V4.K7#EY( MI=6FC.X\\@283/X5G+73N5T.]\-6']E>%].L!:?8Q;VZ1BW\[SO*P/N[\#=C MUQS6I6=X?B$'AS3XDM5M%2W0+ EP9UC&. )#]\>_>M&M)_$R8[(*XJ?P-JEM M/?#P]XFDTZQOII)Y[1["&<[WY;:[#(R23\P;&?3BNUKR/7H/AC/XDOUO]*U2 M[U)YV3-O]LVW5QGYHHBK!&<9Y P!SG&#C)ZNWE_6G4KH>C^%]._LCPKING_9 MC:FVMDC,!F\TQX'3?@;OK@5JUGZ##]F\/V,(L6T\1P(HM'E\UH>/NELG<1TS MDUH5K-WDV1'X4%<3>?"CP]>ZG+?&XUF"62=[C;;:K/$B2/G>RJK +G)SCUKM MJ*BVMRNEB"QLTT_3X+.%Y9$@C$:O-(9'8 8RS-R3[FIZ**IN[NPV"N-/CZX^ MTWDZ^'+V31;6XDMGU&%U=E>,E7)A'SA PQD9/?&.:[*H@MO:Y*K%#YTF3@!= M[G^9-2[] Z&?X7UEO$/A33-8>(0M?6R3F-6R%W#.,]ZU:Q=*A>'Q-K"B-H[? MR[<1 +A/NMG;V_*MJJ;3;:5A1U05XOXX\+^#9M;@\0?V@RQ3ZEY-_9JMS(9F MB8^;Y2Q?,K#^(X*\9RO4^T5Y>\OAOP]XROM0L_!/BV343),KW=O:7$T+&0Y= MHU+E!N(!R%%9OXD^VOY?@4U>#7?_ (/XGH6B#3QH-C_8CK)IWD)]F97+@QX^ M4AB23QZU>K+\,VEK8^%M-MM/M[FVMHK=%CANUVRH,=''9O6M2M9_$R(_"@KQ MCXB:W-!JTMC=>(=+U'2;6Y\VYL_[9.G75N77"1NRO%KZW MTJ#Q1_P#7D6_A M_KS_ *_X8]5\,17,'A73([^^34+E;6,272-N68[1\P/<'U[]:U*P/ GV,^ - M$.EK,MF;*,PB<@OMV\;L<9^G%;];U/C?J1#X4%>/:EXEO-,U?5+(ZMIWAQ/M MK -YG7" XR0PUX!XGU9XO%FIK=Z#XA\43173B'5 MM)U"]BMK(9XC98EV*4Z-C>3C)YR*QE\7R?Z?+[]#3[/S_P _ZTU^5SVGPJ&' MA'2Q)IJZ4WV5,V*]+1?=G.T?,/ MK6M6T_C9G#X4%>&ZW-+<>(-6ET+4[;0["VNY1?6-SXG>RDG! M##=G=QFOA:1?W<=U?:797-Q']R::W1W3Z,1D5DU=W_K_@^A=]+?U_7F H5_"UC:&UD&&B7'"G_'O6O1THJY.[;)BK)(__V0$! end GRAPHIC 6 image5.jpg begin 644 image5.jpg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end GRAPHIC 7 image6.jpg begin 644 image6.jpg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end